Investor Relations

CORPORATE PROFILE


Ironshore Pharmaceuticals Inc. develops novel therapeutics by leveraging its proprietary controlled-release drug-delivery technology. Our lead products are targeted at helping ADHD patients and their families to address significant unmet medical needs.

CORPORATE PROFILE


Press Releases

Publications

Sign up for company updates on our products and market news

SUBSCRIBE
Sign-Up

Get the latest company updates on our products and marketing news.

Sign-Up

Get the latest company updates on our products and marketing news.

© 2023 Ironshore Pharmaceuticals, Inc. | IP001327 09/22 | Site Design: Digital Elevator